MAVIPAN: My Life and the COVID-19 Pandemic

NCT04575571 | Unknown

• 1 other identifier: To be assigned
• Study Type: observational
• Target: 5,000
• Locations: 1 country
• Sites: 1

Brief Summary

The health crisis imposed by COVID-19 is forcing major worldwide social reorganization that will have profound consequences on our society. Currently, one-third of the world's population (\~3 billion individuals) is living under some kind of isolation or quarantine measures, causing an unprecedented and rapidly evolving psychosocial crisis. The psychosocial consequences of this health crisis will persist long after restriction measures are lifted and the pandemic is over. This impact will be significant for individuals facing unique contexts or challenges (e.g., older adults, individuals living with a disability, underprivileged families) and will most likely exacerbate existing social and gender inequalities in health and human development. There is an urgent need for information on the evolution of the psychosocial dimensions of health and coping strategies used by our population and our health and social services structures. Thus, this study is designed to accelerate the availability of high-quality, real-time evidence within health and social services structures to address, support and minimize psychosocial consequences of the COVID-19 pandemic. Through constantly evolving research questions responsive to the course of the pandemic evolution, the rapid system transformations and adaptation of services, and knowledge users (KUs) needs, MAVIPAN aims to address, document, monitor, and evaluate the following:

1. 1.Individuals and families' adjustments and mitigation strategies, especially for those considered vulnerable and in high-risk contexts.
2. 2.Healthcare and social services workers and managers' adjustments and mitigation strategies.
3. 3.The organization of service structures.
4. 4.The social and economic response.

Conditions

Psychosocial Impacts of the COVID-19 Pandemic

Keywords

Psychological Distress; Coping Behaviors; Covid19

Outcome Measures

Primary Outcomes (21)

• Depression, Anxiety and Stress Scale-21 (DASS-21)

  The DASS-21 is a measure of depression, anxiety and stress symptoms. The score on each subscale varies from 0 to 21. A higher score means a higher level of symptoms.

  Baseline (measured during lockdown in March 2020)

• Depression, Anxiety and Stress Scale-21 (DASS-21)

  The DASS-21 is a measure of depression, anxiety and stress symptoms. The score on each subscale varies from 0 to 21. A higher score means a higher level of symptoms.

  3 months

• Depression, Anxiety and Stress Scale-21 (DASS-21)

  The DASS-21 is a measure of depression, anxiety and stress symptoms. The score on each subscale varies from 0 to 21. A higher score means a higher level of symptoms.

  7 months

• Insomnia Severity Index

  Scores vary between 0 and 28. A higher score means greater insomnia severity.

  Baseline (measured during lockdown in March 2020)

• Insomnia Severity Index

  Scores vary between 0 and 28. A higher score means greater insomnia severity.

  3 months

• Insomnia Severity Index

  Scores vary between 0 and 28. A higher score means greater insomnia severity.

  7 months

• Warwick-Edinburgh Mental Well-Being Scale

  Scores range from 7 to 35 and higher scores indicate higher positive well-being.

  Baseline (measured during lockdown in March 2020)

• Warwick-Edinburgh Mental Well-Being Scale

  Scores range from 7 to 35 and higher scores indicate higher positive well-being.

  3 months

• Warwick-Edinburgh Mental Well-Being Scale

  Scores range from 7 to 35 and higher scores indicate higher positive well-being.

  7 months

• Hostility subscale- Symptoms Checklist-90-Revised

  Only the Hostility subscale that measures thoughts, feelings and actions characteristic of anger is used. Scores range from 6 to 24 and higher scores indicate higher level of hostility

  Baseline (measured during lockdown in March 2020)

• Hostility subscale- Symptoms Checklist-90-Revised

  Only the Hostility subscale that measures thoughts, feelings and actions characteristic of anger is used. Scores range from 6 to 24 and higher scores indicate higher level of hostility

  3 months

• Hostility subscale- Symptoms Checklist-90-Revised

  Only the Hostility subscale that measures thoughts, feelings and actions characteristic of anger is used. Scores range from 6 to 24 and higher scores indicate higher level of hostility

  7 months

• Substance use

  These are self-report questions that measure the change in consumption level of different substances such as alcool, prescriptions medications and illicit drugs prior and after the lockdown.

  Baseline (measured during lockdown in March 2020)

• Substance use

  These are self-report questions that measure the change in consumption level of different substances such as alcool, prescriptions medications and illicit drugs prior and after the lockdown.

  3 months

• Substance use

  These are self-report questions that measure the change in consumption level of different substances such as alcool, prescriptions medications and illicit drugs prior and after the lockdown.

  7 months

• Brief COPE

  We use a subset of questions taken from the Brief Cope which measures coping strategies.

  Baseline (measured during lockdown in March 2020)

• Dyadic Adjustment Scale

  We use a subset of questions taken from the Dyadic Adjustment Scale which measures couple satisfaction.

  Baseline (measured during lockdown in March 2020)

• Parental Stress Index

  We only use the Interaction subscale which measures the extent to which the parent believes the child is not meeting expectations and finds interactions with the child are not reinforcing his parenting role.

  Baseline (measured during lockdown in March 2020)

• Child Conflict Tactic Scale

  We use a subset of questions that measures the presence of minor physical abuse as well as psychological abuse.

  Baseline (measured during lockdown in March 2020)

• Strengths and Difficulties Questionnaire

  We use a subset of questions that aim to measure different child behaviors and personality caracteristics.

  Baseline (measured during lockdown in March 2020)

• Healthcare workers adaptation

  We use a series of questions that assess different changes that may have occured in their work, as well as a series of beliefs they may hold concerning their work and their patients/clients.

  Baseline (measured during lockdown in March 2020)

Interventions

No intervention, this is an observational study that uses validated questionnaires and qualitative interviews.. OTHER

No intervention, this is an observational study that uses validated questionnaires and qualitative interviews.

Eligibility Criteria

• Age: 14 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

MAVIPAN is open to any individuals aged 14 and over across the Province of Quebec. We are particularly invested in recruiting vulnerable populations (e.g., older adults, individuals living with a disability or a chronic or mental health condition, child protection families, individuals living in institutional settings) and populations that have become vulnerable because of the COVID-19 context (e.g., healthcare and social services workers, adolescents, caregivers).

You may qualify if:

• General population

You may not qualify if:

• Not a resident of the province of Quebec
• Age under 14

Sponsors & Collaborators

• Laval University: lead
• VITAM: Research Center on Sustainable Health: collaborator
• Centre de recherche CERVO: collaborator
• Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale: collaborator
• Centre de recherche universitaire sur les jeunes et les familles: collaborator
• Réseau québécois de recherche sur le vieillissement: collaborator
• Participation sociale et villes inclusives: collaborator
• Société inclusive: collaborator
• CISSS de Chaudière-Appalaches: collaborator
• Centre intégré de santé et de services sociaux de la Côte-Nord: collaborator
• Fondation Mirella et Lino Saputo: collaborator
• Ville de Québec: collaborator
• Living Lab de Charlevoix: collaborator
• Centre intégré de santé et de services sociaux du Bas St-Laurent: collaborator
• Réseau provincial de recherche en adaptation réadaptation: collaborator
• Réseau international sur le Processus de production du handicap: collaborator
• Centre de recherche intégrée pour un système apprenant en santé et services sociaux: collaborator
• Regroupement des organismes de personnes handicapées de la région 03: collaborator

Study Sites (1)

VITAM-Research Center in Sustainable Health

Québec, G1J 0A4, Canada

RECRUITING

Related Publications (1)

• LeBlanc A, Baron M, Blouin P, Tarabulsy G, Routhier F, Mercier C, Despres JP, Hebert M, De Koninck Y, Cellard C, Collin-Vezina D, Cote N, Dionne E, Fleet R, Gagne MH, Isabelle M, Lessard L, Menear M, Merette C, Ouellet MC, Roy MA, Saint-Jacques MC, Savard C; MAVIPAN Research Collaboration. For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol. BMJ Open. 2022 Apr 4;12(4):e048749. doi: 10.1136/bmjopen-2021-048749.

  PMID: 35379610 DERIVED

Related Links

• Official web site of the study

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Annie LeBlanc, PhD

  Faculty of Medecine, Laval University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Annie LeBlanc, PhD

CONTACT

418-663-5712; annie.leblanc@fmed.ulaval.ca

Marie Baron, PhD

CONTACT

marie.baron.ciussscn@ssss.gouv.qc.ca

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Full Professor

Study Record Dates

• First Submitted: September 24, 2020
• First Posted: October 5, 2020
• Study Start: April 29, 2020
• Primary Completion: April 29, 2025
• Study Completion: April 29, 2025
• Last Updated: October 5, 2020

Record last verified: 2020-10

Locations

CA (1)